Transdermal fentanyl reduces pain and improves functional activity in neuropathic pain states

Pain Medicine

Volumn 8, Issue 7, 2007, Pages 554-562

  Agarwal, Shefali ^a   Polydefkis, Michael ^a   Block, Brian ^a   Haythornthwaite, Jennifer ^b   Raja, Srinivasa N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Activity; Actiwatch; Neuropathic Pain; Transdermal

Indexed keywords

FENTANYL; GABAPENTIN; LIDOCAINE; METHADONE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ACTIMETRY; ADULT; AFFECT; AMPUTATION; ANALGESIA; ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COMPLEX REGIONAL PAIN SYNDROME TYPE I; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DROWSINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; NEUROPATHIC PAIN; OPEN STUDY; PAIN ASSESSMENT; PHYSICAL ACTIVITY; PHYSIOTHERAPY; POSTOPERATIVE PAIN; SEDATION; SIDE EFFECT; SKIN MANIFESTATION; TRANSDERMAL PATCH; UNSPECIFIED SIDE EFFECT; VOMITING;

ADMINISTRATION, CUTANEOUS; ANALGESICS, OPIOID; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PAIN; PAIN MEASUREMENT; RECOVERY OF FUNCTION; TREATMENT OUTCOME;

EID: 34848895455     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2006.00246.x     Document Type: Article

References (32)

1. Foley KM. Opioids and chronic neuropathic pain. N Engl J Med 2003; 348: 1279-81.
2. Zieglgansberger W, Berthele A, Tolle TR. Understanding neuropathic pain. CNS Spectr 2005; 10: 298-308.
3. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain 1999; 83: 389-400.
4. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005; 116: 109-18.
5. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005; 115: 254-63.
6. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2002; 59: 1015-21.
7. Rowbotham MC, Twilling L, Davies PS, et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Medical 2003; 348: 1223-32.
8. Watson CP, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy. Pain 2003; 105: 71-8.
9. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain 2004; 112: 372-80.
10. Cherny NJ, Chang V, Frager G, et al. Opioid pharmacotherapy in the management of cancer pain: A survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer 1995; 76: 1283-93.
11. Bruera E, Palmer JL, Bosnjak S, et al. Methadone versus morphine as a first-line strong opioid for cancer pain: A randomized, double-blind study. J Clin Oncol 2004; 22: 185-92.
12. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003; 349: 1943-53.
13. Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage 1992; 7: 69-77.
14. Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain 1992; 8: 77-85.
15. Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage 1997; 13: 254-61.
16. Payne R, Mathias SD, Pasta DJ, et al. Quality of life and cancer pain: Satisfaction and side effects with transdermal fentanyl versus oral morphine. J Clin Oncol 1998; 16: 1588-93.
17. Mystakidou K, Befon S, Tsilika E, et al. Use of TTS fentanyl as a single opioid for cancer pain relief: A safety and efficacy clinical trial in patients naive to mild or strong opioids. Oncology 2002; 62: 9-16.
18. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005; 113: 9-19.
19. Kahneman D, Krueger AB, Schkade DA, Schwarz N, Stone AA. A survey method for characterizing daily life experience: The day reconstruction method. Science 2004; 306: 1776-80.
20. Merskey H, Bogduk N. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definition of Terms. Seattle, WA: IASP Press; 1995.
21. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state."A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
22. Jean-Louis G, Zizi F, von Gizycki H, Hauri P. Actigraphic assessment of sleep in insomnia: Application of the Actigraph Data Analysis Software (ADAS). Physiol Behav 1999; 65: 659-63.
23. Puyau MR, Adolph AL, Vohra FA, Butte NF. Validation and calibration of physical activity monitors in children. Obes Res 2002; 10: 150-7.
24. Liszka-Hackzell JJ, Martin DP. An analysis of the relationship between activity and pain in chronic and acute low back pain. Anesthesia Analgesia 2004; 99: 477-81.
25. Wechsler D. Wechsler Adult Intelligence Scale-Revised (WAIS-R). New York: The Psychological Corporation; 1981.
26. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale multidimensional pain inventory (WHYMPI). Pain 1985; 23: 345-56.
27. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71.
28. Haythornthwaite JA, Sieber WJ, Kerns RD. Depression and the chronic pain experience. Pain 1991; 46: 177-84.
29. Clark AJ, Ahmedzai SH, Allan LG, et al. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain. Curr Med Res Opin 2004; 20: 1419-28.
30. Shirota A, Tamaki M, Havashi M, et al. Effects of daytime activity on nocturnal sleep in the elderly. Psychiatry Clin Neurosci 2000; 54: 309-10.
31. Tryon WW. Issues of validity in actigraphic sleep assessment. Sleep 2004; 27: 158-65.
32. Stone AA, Broderick JE, Schwartz JE, et al. Intensive momentary reporting of pain with an electronic diary: Reactivity, compliance, and patient satisfaction. Pain 2003; 104: 343-51.